ABIVAX Société Anonyme
ABVX
$82.28
-$3.59-4.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -80.32% | -19.91% | 70.52% | 73.97% | 393.52% |
| Total Revenue | -80.32% | -19.91% | 70.52% | 73.97% | 393.52% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -80.32% | -19.91% | 70.52% | 73.97% | 393.52% |
| SG&A Expenses | -21.72% | -14.76% | -24.35% | -22.83% | 244.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -169.07% | -94.62% | -3,935.81% | -4,005.05% | -410.53% |
| Total Operating Expenses | 22.46% | 1.85% | 3.91% | 6.00% | 104.82% |
| Operating Income | -38.78% | -2.43% | -2.19% | -4.25% | -87.40% |
| Income Before Tax | -31.67% | -18.43% | 2.21% | 0.24% | -47.59% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.67% | -18.43% | 2.21% | 0.24% | -47.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.67% | -18.43% | 2.21% | 0.24% | -47.59% |
| EBIT | -38.78% | -2.43% | -2.19% | -4.25% | -87.40% |
| EBITDA | -39.15% | -2.39% | -1.88% | -3.93% | -87.20% |
| EPS Basic | -30.59% | -17.58% | 22.25% | 20.68% | 15.78% |
| Normalized Basic EPS | -30.59% | -11.14% | 24.77% | 23.24% | 15.79% |
| EPS Diluted | -30.59% | -17.58% | 22.25% | 20.68% | 15.78% |
| Normalized Diluted EPS | -30.59% | -11.14% | 24.77% | 23.24% | 15.79% |
| Average Basic Shares Outstanding | 0.83% | 0.73% | 25.77% | 25.77% | 75.24% |
| Average Diluted Shares Outstanding | 0.83% | 0.73% | 25.77% | 25.77% | 75.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |